Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A well differentiated, low or intermediate grade tumor with neuroendocrine differentiation that arises from the stomach.
Biomarker and diagnostic research for gastric neuroendocrine tumor, well differentiated, low or intermediate grade has been reported in the published literature.
1 clinical trial registered. Interventions under study include drug therapy, other interventions, and biologic therapy. Pipeline includes 1 PHASE3. Research is primarily sponsored by academic and government institutions.
244 publications have been identified in PubMed for gastric neuroendocrine tumor, well differentiated, low or intermediate grade. Kisho has analyzed 121 by research type. Research spans Review / Meta-Analysis (34%), Basic Science / Preclinical (18%), and Epidemiology / Natural History (16%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 4:38 PM UTC
34% |
Laboratory research | 22 | 18% |
Disease patterns and progression | 19 | 16% |
Clinical study results | 15 | 12% |
Testing and diagnosis research | 14 | 12% |
Patient case studies | 9 | 7% |
New treatment approaches | 1 | 1% |
Scuderi S (2026). [PMID: 41002165](https://pubmed.ncbi.nlm.nih.gov/41002165/). *J Natl Cancer Inst*. [Diagnostic / Biomarker]
Mduma E (2026). [PMID: 41869226](https://pubmed.ncbi.nlm.nih.gov/41869226/). *Cureus*. [Case Report / Case Series]
Fazio N (2026). [PMID: 41063652](https://pubmed.ncbi.nlm.nih.gov/41063652/). *Endocr Rev*. [Review / Meta-Analysis]
Nilsson P (2026). [PMID: 41655576](https://pubmed.ncbi.nlm.nih.gov/41655576/). *Lancet Oncol*. [Clinical Trial Publication]
Brat DJ (2026). [PMID: 42152226](https://pubmed.ncbi.nlm.nih.gov/42152226/). *Neuro Oncol*. [Basic Science / Preclinical]
Lin MC (2026). [PMID: 42046288](https://pubmed.ncbi.nlm.nih.gov/42046288/). *Head Neck*. [Epidemiology / Natural History]
Živić K (2026). [PMID: 41677640](https://pubmed.ncbi.nlm.nih.gov/41677640/). *Cells*. [Basic Science / Preclinical]
Tanguy R (2026). [PMID: 42115465](https://pubmed.ncbi.nlm.nih.gov/42115465/). *Adv Tech Stand Neurosurg*. [Review / Meta-Analysis]
van den Heerik ASVM (2026). [PMID: 41449145](https://pubmed.ncbi.nlm.nih.gov/41449145/). *Lancet Oncol*. [Clinical Trial Publication]
Al-Toubah T (2026). [PMID: 41028638](https://pubmed.ncbi.nlm.nih.gov/41028638/). *Ann Surg Oncol*. [Clinical Trial Publication]